| Parameter | β | SE | P | OR | 95% CI |
---|---|---|---|---|---|---|
X1 | Age | −0.5341 | 0.26 | 0.04 | 0.586 | 0.352–0.976 |
X2 | Occupation | −0.2695 | 0.1221 | 0.0273 | 0.764 | 0.601–0.970 |
X3 | Menarche | 0.2967 | 0.233 | 0.2029 | 1.345 | 0.852–2.124 |
X4 | Menopausal status | −0.00174 | 0.2056 | 0.9933 | 0.998 | 0.667–1.494 |
X5 | Delay in diagnosis (days) | −0.00233 | 0.086 | 0.9784 | 0.998 | 0.843–1.181 |
X6 | Tumor primary site | 0.3760 | 0.2048 | 0.0664 | 1.457 | 0.975–2.176 |
X7 | Tumor primary quadrant | −0.1329 | 0.1088 | 0.2218 | 0.876 | 0.707–1.084 |
X8 | Tumor Size | −0.0365 | 0.2109 | 0.8626 | 0.964 | 0.638–1.458 |
X9 | Pathology | 0.1599 | 0.3748 | 0.6697 | 1.173 | 0.563–2.446 |
X10 | ER | −0.0632 | 0.2547 | 0.804 | 0.939 | 0.570–1.546 |
X11 | PR | −0.0323 | 0.2209 | 0.8839 | 0.968 | 0.628–1.493 |
X12 | HER2 | −0.0487 | 0.2806 | 0.8621 | 0.952 | 0.549–1.651 |
X13 | Triple negative | −0.1542 | 0.3865 | 0.69 | 0.857 | 0.402–1.828 |
X14 | Ki-67 | −0.0570 | 0.2503 | 0.8199 | 0.945 | 0.578–1.543 |
X15 | Tumor grade | 0.0994 | 0.1481 | 0.502 | 1.105 | 0.826–1.476 |
X16 | Postoperative ALNs | −0.0632 | 0.089 | 0.4778 | 0.939 | 0.789–1.118 |
X17 | Ratio of positive to total SLNs | 0.9606 | 0.215 | < 0.0001 | 2.613 | 1.715–3.983 |